文献速递胸部技术与安全CT

胸部CT定量肌少症与脂肪减少症对接受异基因造血干细胞移植的重型再生障碍性贫血患者的预后影响

Prognostic Impact of Quantifying Sarcopenia and Adipopenia by Chest CT in Severe Aplastic Anemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation.
PubMed 文献 · Acad Radiol · 2022-11-12

本研究回顾性纳入123例接受造血干细胞移植的重型再生障碍性贫血患者,通过胸部CT测量胸肌指数(PMI)和皮下脂肪组织指数(SAI),以性别特异性中位数定义肌少症和脂肪减少症。肌少症组(47.2%)3年总生存率和无失败生存率显著更差,肌少症状态和诊断分类是独立预后因素,据此构建的列线图1年和3年AUC分别为0.801和0.721。结论提示肌少症提示不良预后,移植前建议加强支持治疗。

要点

  • 胸部CT可定量胸肌指数和皮下脂肪指数,肌少症定义为PMI低于性别特异性中位数。
  • 肌少症组3年OS和FFS显著低于非肌少症组,肌少症是独立不良预后因素。
  • 基于肌少症和诊断分类的列线图对1年和3年生存有较好预测能力。

局限性

  • 回顾性研究设计。
  • 单中心 consecutive 样本,样本量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To investigate the prognostic role of chest CT-defined sarcopenia and adipopenia in severe aplastic anemia (SAA) patients treated with hematopoietic stem cell transplantation (HSCT).

MATERIALS AND METHODS: This was a retrospective study of 123 consecutive SAA patients treated with HSCT. CT imaging was performed to quantify the pectoralis muscle (including major and minor) index (PMI) and the corresponding subcutaneous adipose tissue index (SAI). Sarcopenia and adipopenia were defined as PMI and SAI lower than the respective sex-specific medians. Correlations of the PMI and SAI with anthropometric indexes were calculated. Transplant-related outcomes were compared between the sarcopenia and adipopenia groups. Prognostic factors for overall survival (OS) and fail-free survival (FFS) were identified by Cox regression and were used to create a nomogram. The accuracy of the nomogram was evaluated by ROC curves.

RESULTS: PMI showed good correlation with BMI and fat-free mass index (p < 0.001). SAI correlated with BMI and fat mass index (p < 0.001). The sarcopenia group (47.2%) had a significantly worse 3-year OS (90.8% vs. 77.6%, p = 0.045) and 3-year FFS (89.2% vs. 74.1%, p = 0.035) than the nonsarcopenia group. Sarcopenia status and diagnostic category were used to construct the nomogram of OS, as these were independent prognostic factors in the multivariate analysis for OS and FFS (p < 0.05). The area under the curve of the nomogram at one year and three years was 0.801 and 0.721, respectively.

CONCLUSION: Sarcopenia indicates a poor prognosis in SAA patients undergoing HSCT. Intensive supportive care is suggested for SAA patients with sarcopenia before transplantation.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Chen, Yuan, Guo, et al. Prognostic Impact of Quantifying Sarcopenia and Adipopenia by Chest CT in Severe Aplastic Anemia Patients Treated With Allogeneic Hematopoietic Stem Cell Transplantation. Acad Radiol. 2022. PMID: 36379814. doi:10.1016/j.acra.2022.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。